How to choose a biomarker-guided longevity program

What these programs promise

Biomarker-guided longevity programs typically offer a big blood panel, sometimes repeated once or twice a year, along with a dashboard, scores and recommendations. Some add imaging, genetic tests or wearables. The appeal is clear: catch problems early and track progress with numbers.

The challenge is that more tests do not automatically mean better care. Each extra marker raises the chance of a borderline or out-of-range result that leads to repeat testing, worry or treatment that does not improve health.

Markers with strong evidence

• Blood pressure, ideally confirmed with validated home readings
• LDL cholesterol and ApoB for atherosclerotic risk
• Lipoprotein(a), which the 2026 ACC/AHA dyslipidemia guideline recommends measuring at least once in all adults
• Fasting glucose or A1c to screen for prediabetes and diabetes
• Kidney function (creatinine with eGFR) and urine albumin in people at risk
• A complete blood count and ferritin when symptoms suggest anemia or iron deficiency

Markers that need more caution

Some tests have good uses in specific situations but are less helpful as routine screening. The U.S. Preventive Services Task Force found insufficient evidence to add hs-CRP or coronary calcium scoring to routine risk assessment for everyone, even though these tests can help refine decisions in selected people.

Other offerings, such as biological age clocks, extensive micronutrient panels or broad hormone panels in people without symptoms, may be interesting but have limited evidence that acting on them improves health outcomes. A program should be able to explain what decision each test supports.

Retesting: matching frequency to the marker

Different markers change at different speeds. Lipoprotein(a) is largely set by your genes, so one result is usually enough. A1c reflects about three months of blood sugar, so testing more often than that adds little. Blood pressure can be tracked at home as often as is useful. Ferritin and vitamin D respond to treatment over weeks to months. A program that retests everything on the same schedule is probably not thinking about what each number means.

Whole-body imaging

Some programs add whole-body CT or MRI scans. FDA states that it knows of no scientific evidence that whole-body CT scanning of people without symptoms does more good than harm, notes the radiation exposure, and warns that false alarms can lead to unnecessary, sometimes invasive, follow-up. Targeted screening for specific risks, such as lung cancer screening for eligible smokers, is a different matter.

Why fewer, better tests often win

Each lab test has a small chance of producing a result outside its reference range in a healthy person. Run enough tests and an unusual result becomes almost certain. That is not a flaw in any one test; it is a feature of large panels. The consequence is extra appointments, repeat draws and sometimes imaging or procedures that were never needed.

A focused panel chosen for your situation avoids much of that. It also makes it easier to see what is changing over time, since you are tracking a handful of meaningful markers rather than scanning dozens of numbers each year.

What good looks like

• A licensed clinician reviews results with you, not just an automated report
• Testing is matched to your age, sex, history and family history
• Findings lead to concrete steps: lifestyle, medication, referral or simply retesting
• Results are compared with the lab's own reference ranges and with your past results
• Retest intervals reflect how quickly each marker changes
• The program is clear about which tests have strong evidence and which are exploratory

Red flags

• Scores or biological ages presented as precise predictions
• Supplements sold to correct every out-of-range number
• Whole-body scans marketed for people without symptoms
• No clinician available to discuss abnormal results
• Frequent retesting that mostly measures normal variation

Questions to ask

• Which markers do you test, and what would each one change?
• Who interprets my results, and can I talk with them?
• How do you handle a borderline result?
• How often do you recommend retesting, and why?
• Can you prescribe treatment, or will I need to see someone else?

Applying this to HealifyMD

HealifyMD offers a Comprehensive Lab Panel for $199, with results reviewed by a licensed clinician who can discuss treatment options where appropriate. Specialty tests are available when they would answer a specific question. Prices are confirmed during your eligibility review. As with any program, ask what each test is for.